Kobo Biotech Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Net Income	-49.29	-55.53	-152.26	-192.31	-210.06
Depreciation & Amortization	40.71	40.72	46.06	56.37	58.78
Other Operating Activities	-	-	1.34	108.41	144.75
Change in Accounts Receivable	-0.13	-1.56	806.75	8.14	-26.8
Change in Inventory	-	-	352.38	-	-
Change in Accounts Payable	10.45	25.63	-82.79	33.72	-
Change in Other Net Operating Assets	0.29	-0.51	-33.92	10.77	178.09
Operating Cash Flow	2.04	8.75	937.57	25.09	144.76
Operating Cash Flow Growth	-76.72%	-99.07%	3636.53%	-82.67%	-30.89%
Capital Expenditures	-	-	-	-	-0.03
Sale of Property, Plant & Equipment	-	-	128.92	-	-
Investment in Securities	-	-	121.93	-	-
Other Investing Activities	-	-	0.05	-	-
Investing Cash Flow	-	-	250.9	-	-0.03
Short-Term Debt Issued	7.96	-	-	111.62	-
Total Debt Issued	7.96	-	-	111.62	-
Short-Term Debt Repaid	-	-	-1,198	-	-
Long-Term Debt Repaid	-9.46	-8.74	-3.31	-13.99	-
Total Debt Repaid	-9.46	-8.74	-1,201	-13.99	-
Net Debt Issued (Repaid)	-1.5	-8.74	-1,201	97.63	-
Other Financing Activities	-	-	-1.34	-108.41	-144.75
Financing Cash Flow	-1.5	-8.74	-1,203	-10.77	-144.75
Net Cash Flow	0.54	0.01	-14.34	14.32	-0.02
Free Cash Flow	2.04	8.75	937.57	25.09	144.73
Free Cash Flow Growth	-76.72%	-99.07%	3636.53%	-82.66%	-30.90%
Free Cash Flow Per Share	0.09	0.37	39.35	1.05	6.08
Cash Interest Paid	-	-	1.34	108.41	144
Levered Free Cash Flow	20.42	32.92	975.9	-7.52	-76.99
Unlevered Free Cash Flow	20.42	32.92	976.74	59.98	13.01
Change in Working Capital	10.61	23.56	1,042	52.63	151.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.